FDA D.I.S.C.O. Burst Edition: FDA approval of Imfinzi (durvalumab) for adult patients with locall...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for the adjuvant treatment...

(3:31)

FDA D.I.S.C.O.: Rucaparib in Ovarian Cancer

(5:15)

FDA D.I.S.C.O.: Intro by Dr. Richard Pazdur

(3:21)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) as adjuvant treatment for ...

(3:31)

FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

(6:1econd)

FDA D.I.S.C.O.: A new treatment for acute myelogenous leukemia

(5:1econd)

Navigating FDA's Drug Information Resources

(50:52)

Understand the Applicability of FDA’s Computer Software Assurance Guidance to Data Integrity

(1:6:45)

FDA D.I.S.C.O. Burst Edition: FDA approval of Tecelra (afamitresgene autoleucel) for unresectable...

(3:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approvals of Augtyro (repotrectinib) for NTRK gene fusion-posit...

(5:1econd)

VIDEO: How AI Is Fueling the Transformation of Healthcare

(46:20)

FDA D.I.S.C.O. Burst Edition: FDA approval of Ojemda (tovorafenib) for relapsed or refractory ped...

(4:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Retevmo (selpercatinib) for advanced or metastatic ...

(4:1econd)

AUDIO: How AI Is Fueling the Transformation of Healthcare

(46:20)

FDA D.I.S.C.O.: First Tissue/Site Agnostic Approval Transcript

(6:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for high-risk early-stage ...

(4:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with trastu...

(3:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Brukinsa (zanubrutinib) for adult patients with Wal...

(3:1econd)

FDA D.I.S.C.O. Burst Edition: Libtayo (cemiplimab-rwlc) for patients with locally advanced or met...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) in combination with Lenvim...

(4:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for unresectable advanced ...

(3:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Tafinlar (dabrafenib) in combination with Mekinist ...

(5:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approval of Scemblix (asciminib) for patients with Philadelphia...

(4:1econd)

FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma

(5:31)

FDA D.I.S.C.O.: First biosimilar approval for the treatment of cancer

(8:31)

FDA D.I.S.C.O. Burst Edition: FDA approval of Cabometyx (cabozantinib) for locally advanced or me...

(3:1econd)

FDA D.I.S.C.O. Burst Edition: FDA approves a new dosing regimen for asparaginase erwinia chrysant...

(4:1econd)